Brisotto, G.; Biscontin, E.; Rossi, E.; Bulfoni, M.; Piruska, A.; Spazzapan, S.; Poggiana, C.; Vidotto, R.; Steffan, A.; Colombatti, A.;
et al. Dysmetabolic Circulating Tumor Cells Are Prognostic in Metastatic Breast Cancer. Cancers 2020, 12, 1005.
https://doi.org/10.3390/cancers12041005
AMA Style
Brisotto G, Biscontin E, Rossi E, Bulfoni M, Piruska A, Spazzapan S, Poggiana C, Vidotto R, Steffan A, Colombatti A,
et al. Dysmetabolic Circulating Tumor Cells Are Prognostic in Metastatic Breast Cancer. Cancers. 2020; 12(4):1005.
https://doi.org/10.3390/cancers12041005
Chicago/Turabian Style
Brisotto, Giulia, Eva Biscontin, Elisabetta Rossi, Michela Bulfoni, Aigars Piruska, Simon Spazzapan, Cristina Poggiana, Riccardo Vidotto, Agostino Steffan, Alfonso Colombatti,
and et al. 2020. "Dysmetabolic Circulating Tumor Cells Are Prognostic in Metastatic Breast Cancer" Cancers 12, no. 4: 1005.
https://doi.org/10.3390/cancers12041005
APA Style
Brisotto, G., Biscontin, E., Rossi, E., Bulfoni, M., Piruska, A., Spazzapan, S., Poggiana, C., Vidotto, R., Steffan, A., Colombatti, A., Huck, W. T. S., Cesselli, D., Zamarchi, R., Turetta, M., & Del Ben, F.
(2020). Dysmetabolic Circulating Tumor Cells Are Prognostic in Metastatic Breast Cancer. Cancers, 12(4), 1005.
https://doi.org/10.3390/cancers12041005